Dean Investment Associates LLC Has $7 Million Position in BlackRock, Inc. (BLK)

Share on StockTwits

Dean Investment Associates LLC boosted its position in shares of BlackRock, Inc. (NYSE:BLK) by 6.7% during the 1st quarter, Holdings Channel reports. The firm owned 16,372 shares of the asset manager’s stock after acquiring an additional 1,024 shares during the quarter. BlackRock makes up about 1.0% of Dean Investment Associates LLC’s portfolio, making the stock its 15th biggest position. Dean Investment Associates LLC’s holdings in BlackRock were worth $6,997,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently modified their holdings of the stock. BKD Wealth Advisors LLC acquired a new position in BlackRock in the fourth quarter valued at about $216,000. BB&T Corp lifted its stake in BlackRock by 2.3% in the fourth quarter. BB&T Corp now owns 4,422 shares of the asset manager’s stock valued at $1,737,000 after buying an additional 99 shares during the period. IFP Advisors Inc lifted its stake in BlackRock by 48.3% in the fourth quarter. IFP Advisors Inc now owns 2,877 shares of the asset manager’s stock valued at $1,117,000 after buying an additional 937 shares during the period. Clean Yield Group acquired a new position in BlackRock in the fourth quarter valued at about $59,000. Finally, Sumitomo Life Insurance Co. lifted its stake in BlackRock by 2.5% in the fourth quarter. Sumitomo Life Insurance Co. now owns 3,579 shares of the asset manager’s stock valued at $1,406,000 after buying an additional 86 shares during the period. Institutional investors own 80.49% of the company’s stock.

Shares of BlackRock stock opened at $435.76 on Friday. BlackRock, Inc. has a 1 year low of $360.79 and a 1 year high of $557.00. The stock has a market capitalization of $67.33 billion, a price-to-earnings ratio of 16.18, a price-to-earnings-growth ratio of 1.59 and a beta of 1.44. The company has a quick ratio of 3.49, a current ratio of 3.49 and a debt-to-equity ratio of 0.83.

BlackRock (NYSE:BLK) last announced its quarterly earnings results on Tuesday, April 16th. The asset manager reported $6.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.13 by $0.48. BlackRock had a return on equity of 13.46% and a net margin of 30.58%. The company had revenue of $3.35 billion during the quarter, compared to the consensus estimate of $3.30 billion. During the same period in the prior year, the company earned $6.48 earnings per share. The company’s revenue for the quarter was down 6.6% compared to the same quarter last year. On average, research analysts predict that BlackRock, Inc. will post 27.78 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Thursday, June 6th will be issued a dividend of $3.30 per share. The ex-dividend date of this dividend is Wednesday, June 5th. This represents a $13.20 dividend on an annualized basis and a dividend yield of 3.03%. BlackRock’s payout ratio is presently 49.02%.

BLK has been the topic of several analyst reports. Jefferies Financial Group raised BlackRock from a “hold” rating to a “buy” rating and set a $405.36 target price on the stock in a research note on Tuesday, January 29th. Morgan Stanley set a $515.00 price target on BlackRock and gave the stock a “buy” rating in a report on Friday, February 8th. Barclays increased their price target on BlackRock from $455.00 to $472.00 and gave the stock an “overweight” rating in a report on Tuesday, February 19th. Zacks Investment Research upgraded BlackRock from a “sell” rating to a “hold” rating in a report on Wednesday, March 6th. Finally, Bank of America restated a “buy” rating and issued a $498.00 price target (up from $490.00) on shares of BlackRock in a report on Friday, March 8th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $509.38.

In related news, COO Robert L. Goldstein sold 5,133 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $443.00, for a total transaction of $2,273,919.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeff A. Smith sold 300 shares of the stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $468.22, for a total value of $140,466.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,658 shares of company stock valued at $18,864,994. 1.42% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Dean Investment Associates LLC Has $7 Million Position in BlackRock, Inc. (BLK)” was first posted by Zolmax and is owned by of Zolmax. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://zolmax.com/investing/dean-investment-associates-llc-has-7-million-position-in-blackrock-inc-blk/3094809.html.

BlackRock Company Profile

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Further Reading: Call Option

Want to see what other hedge funds are holding BLK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock, Inc. (NYSE:BLK).

Institutional Ownership by Quarter for BlackRock (NYSE:BLK)

Receive News & Ratings for BlackRock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Westlake Chemical  Upgraded at ValuEngine
Westlake Chemical Upgraded at ValuEngine
Morgan Stanley Reiterates “$84.00” Price Target for Exxon Mobil
Morgan Stanley Reiterates “$84.00” Price Target for Exxon Mobil
Tenax Therapeutics  versus Its Rivals Critical Contrast
Tenax Therapeutics versus Its Rivals Critical Contrast
Steelcase  Stock Rating Lowered by Zacks Investment Research
Steelcase Stock Rating Lowered by Zacks Investment Research
Consumer Edge Lowers Kellogg  to Underweight
Consumer Edge Lowers Kellogg to Underweight
Grana y Montero SAA  Stock Rating Upgraded by Zacks Investment Research
Grana y Montero SAA Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.